Assessment of Adverse Drug Reactions Associated with Cardiovascular Agents and Antibiotics at a Tertiary Care Hospital
WHO. International drug monitoring the role of national centres. WHO Technical Report Series No. 498; 1972. p. 498.
Couper MR, Mehta DK, editors. WHO Model Formulary 2002. 1st ed. Geneva: World Health Organisation; 2002. p. 9.
Kurokawa T, Correa-Nunes AM, Czarnecki A. Guidelines for setting up and running a pharmacovigilance centre. Sweden: Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring; 2000. p. 4–10.
Sriram S, Ghasemi A, Ramasamy R, Devi M, Balasubramanian R, Ravi TK, et al. Prevalence of adverse drug reactions at a private tertiary care hospital in south India. J Res Med Sci. 2011; 16:16–25. PMid:21448378 PMCid:PMC3063432
Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital–their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003; 12:687–92. https://doi.org/10.1002/pds.871 PMid:14762985
Paudel S, Chetty MS, Laudari S, Subedi ND. Adverse drug reactions of antihypertensive agents at tertiary care hospital in central Nepal. JCMS Nepal. 2017; 13(2):2849. https:// doi.org/10.3126/jcmsn.v13i2.16463
Eisazaei A, Vithya T, Hiremath SRR, Prasad S. Incidence and assessment of adverse drug reactions at a tertiary care hospital. WJPR. 2017; 6(12):967–8.
Khurshid F, Aqil M, Shamshir Alam M, Kapur P, Pillai KK. Monitoring of adverse drug reactions associated with antihypertensive medicines at a university teaching hospital in New Delhi. Daru. 2012; 20(1):34. https://doi.org/10.1186/20082231-20-34 PMid:23351598 PMCid:PMC3555729
- There are currently no refbacks.